TOP STORY
Prostaglandin inhibitors and calcium channel blockers were ranked as the top tocolytic therapy options in terms of outcomes of 48-hour delay in delivery, neonatal mortality, respiratory distress syndrome, and maternal side effects, according to a systematic review and network meta-analysis published Oct. 9 in BMJ. » More |
Continuing Education
Welcome to the third activity of our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The November activity will cover oral antidiabetes agents and noninsulin injectables for diabetes care.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.
Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide
or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at
www.MyCPEmonitor.net. This profile will enable you to have one login
for all the NABP programs and services you will need throughout your career.
|
TODAY'S HEADLINES
The Society of Thoracic Surgeons has updated its clinical practice guidelines on use of antiplatelet drugs during heart surgery. » More |
|
Topical ivermectim provided a good degree of cure in patients with head lice infection with one simple and easy-to-use application, according to a study published in the Nov. 1 issue of the New England Journal of Medicine. » More |
|
Adding aliskiren to standard therapy with renin-angiotensin system blockade could be harmful and did not lower the risk of cardiovascular and renal adverse events when used in patients with type 2 diabetes at risk for these events, according to an online study in the New England Journal of Medicine. » More
|
Drug Topics covers ASHP's 2012 Midyear Clinical Meeting
Drug Topics will be covering the ASHP's 2012 Midyear Clinical Meeting, so be sure to follow us at twitter.com/Drug_Topics for the latest updates from Las Vegas. Also, please stop by our booth #752 in the exhibit hall and pick up the latest edition of Drug Topics. The exhibit hall is open Monday, Dec. 3, from 11 a.m. to 3 p.m.; Tuesday, Dec. 4, from 11 a.m. to 3 p.m.; and Wednesday, Dec. 5, from 11 a.m. to 2 p.m.
|
|
|
Like
Tweet
